Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance

Seth L Toback1, John Herley, Laurel Edelman

  • 1MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA. tobacks@medimmune.com

Vaccine
|April 19, 2011
PubMed

Insights

Pediatric influenza vaccination trends show earlier administration each year, but later season coverage has not improved. This highlights a need to address declining vaccination rates after December.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Annual influenza vaccination is recommended for children.
  • Recent recommendations encourage early and season-long vaccination delivery.
  • Limited data exist on pediatric providers' response to these recommendations.

Purpose of the Study:

  • To describe pediatric providers' response to recent influenza vaccination recommendations.
  • To analyze trends in the timing of influenza vaccination administration in children.

Main Methods:

  • Analysis of de-identified, patient-level data from a large US outpatient healthcare claims database (2006-2010).
  • Projection of weekly influenza vaccination counts for children aged 6 months to 18 years to estimate national trends.
  • Examination of vaccination timing, vaccine types used, and age-specific patterns.

Main Results:

  • Seasonal influenza vaccination peaked earlier each year, shifting from November to September between 2006 and 2009.
  • The proportion of vaccinations administered before November 1 increased annually.
  • Vaccination rates declined sharply in December and continued to decrease throughout the remainder of the season.
  • Vaccine delivery was more spread out for younger children (6-23 months) compared to older children.
  • Use of preservative-free inactivated influenza vaccine and live attenuated influenza vaccine increased in specific age groups.

Conclusions:

  • Pediatric influenza vaccination administration has shifted to earlier in the season.
  • Despite earlier vaccination, coverage in the latter part of the season has not improved.
  • Further strategies may be needed to sustain vaccination rates beyond December.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...